OAK RIDGE INVESTMENTS LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
OAK RIDGE INVESTMENTS LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,280,920
-27.1%
47,671
-3.3%
0.16%
-24.9%
Q2 2023$1,757,824
+35.9%
49,294
-3.2%
0.22%
+24.0%
Q1 2023$1,293,927
-41.0%
50,942
-5.8%
0.18%
-46.5%
Q4 2022$2,194,296
+19.8%
54,100
-2.4%
0.33%
+17.6%
Q3 2022$1,831,000
-6.8%
55,404
-0.7%
0.28%
-2.8%
Q2 2022$1,964,000
+16.3%
55,768
+51.9%
0.29%
+52.1%
Q1 2022$1,689,000
-55.9%
36,721
-36.5%
0.19%
-42.0%
Q4 2021$3,834,000
+4.4%
57,824
-1.7%
0.32%
+0.3%
Q3 2021$3,673,000
-26.8%
58,833
-2.9%
0.32%
-26.3%
Q2 2021$5,020,000
-11.3%
60,618
-29.0%
0.44%
-16.9%
Q1 2021$5,657,000
-16.6%
85,320
-3.5%
0.53%
-11.9%
Q4 2020$6,784,000
+43.1%
88,411
-19.7%
0.60%
+62.1%
Q3 2020$4,741,000
-6.9%
110,101
-6.7%
0.37%
-13.6%
Q2 2020$5,094,000
+34.6%
117,952
-10.3%
0.43%
+10.3%
Q1 2020$3,784,000
-59.5%
131,502
-10.7%
0.39%
-43.6%
Q4 2019$9,343,000
+14.9%
147,293
-49.0%
0.69%
+12.1%
Q3 2019$8,133,000
+1.0%
288,584
-5.0%
0.61%
+10.1%
Q2 2019$8,049,000
+31.8%
303,709
-8.8%
0.56%
+43.3%
Q1 2019$6,108,000
+46.8%
332,868
-0.6%
0.39%
+29.8%
Q4 2018$4,160,000
-42.8%
334,983
-11.7%
0.30%
-25.6%
Q3 2018$7,273,000379,3740.40%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders